Austria’s Digital Pharmacy Landscape: Market Share Outlook 2025
The Austrian online pharmacy market continues its expansion, driven by increasing digital adoption and evolving consumer purchasing habits. As we approach 2025, understanding the projected market shares and underlying dynamics is crucial for stakeholders within the DACH e-commerce sector. This analysis provides a data-centric view of the market’s trajectory and competitive structure.
Market Volume and Growth Trajectory
The Austrian online pharmacy sector, primarily encompassing over-the-counter (OTC) medications, health products, and non-pharmaceutical assortments, has demonstrated consistent growth. While smaller in absolute terms compared to Germany, its relative growth rate reflects a market in maturation.
QuantisIntel data indicates that the total online pharmacy market in Austria reached an estimated €315 million in 2023. This figure represents a 14.5% year-on-year growth from 2022, signaling robust consumer shift towards digital channels for health-related purchases. Projections for 2024 indicate a further expansion to approximately €360 million, with a growth rate of 14.3%.
Looking towards 2025, the market is forecast to maintain a strong growth trajectory, albeit with a slight deceleration as market penetration increases. QuantisIntel projects the Austrian online pharmacy market to reach an estimated €408 million by the end of 2025, representing an 13.3% growth over 2024. These figures are primarily driven by increased consumer confidence in online health purchases, expanded product offerings from retailers, and improvements in logistical efficiency.
The compound annual growth rate (CAGR) for the period 2023-2025 is projected at 14.0%, underscoring the sustained momentum within this segment.
| Metric | Value (2023) | Value (2024E) | Value (2025E) | Change (2023-2025 CAGR) |
|---|---|---|---|---|
| Total Market Volume (EUR mn) | 315 | 360 | 408 | 14.0% |
| Growth Rate (YoY) | 14.5% | 14.3% | 13.3% | N/A |
| Online Penetration (Health/Beauty E-commerce) | 18.2% | 20.5% | 22.8% | N/A |
Note: E = Estimated; CAGR = Compound Annual Growth Rate
Regulatory Framework and its Impact on Market Structure
The regulatory environment significantly shapes the operational scope and market share distribution within the Austrian online pharmacy sector. A primary distinction exists between over-the-counter (OTC) medications and prescription-only (Rx) drugs, known as “rezeptpflichtige Arzneimittel.”
Under current Austrian law, the online sale of prescription-only drugs to end-consumers remains highly restricted. While EU directives permit online sales of Rx drugs under specific conditions, national legislation in Austria has maintained a more conservative stance. The “Apothekengesetz” (Pharmacy Act) and related ordinances primarily mandate that Rx drugs be dispensed by licensed physical pharmacies after a valid prescription has been presented and verified. This legal framework has prevented the widespread market entry of pure-play online pharmacies for Rx drugs, a situation distinct from some other EU member states.
Consequently, the vast majority of the Austrian online pharmacy market volume, as detailed in the previous section, is concentrated in OTC medications, dietary supplements, medical devices, cosmetics, and other health-related products that do not require a prescription. Online pharmacies operating in Austria typically function as mail-order pharmacies (“Versandapotheken”) for non-prescription items.
This regulatory constraint has several implications for market share:
- Dominance of OTC: Market share is almost entirely derived from the non-prescription segment.
- Limited Foreign Pure-Plays for Rx: International online pharmacies that specialize in Rx drugs face significant barriers to entry or operation.
- Hybrid Models: Traditional Austrian pharmacies (“Präsenzapotheken”) with a physical presence are increasingly developing online channels, leveraging their existing dispensing licenses for both Rx and OTC drugs, albeit with Rx still requiring physical prescription verification or secure e-prescription integration. However, their online market share for Rx is still nascent due to logistical and verification challenges.
- Focus on Service and Assortment: Competition for market share in the online segment is intensified around price, product range, delivery speed, and customer service for OTC and health products.
The ongoing discussions regarding the implementation of a comprehensive e-prescription system (“E-Rezept”) in Austria could introduce changes to this landscape. However, as of early 2024, its full integration and impact on online Rx drug dispensing are still in developmental stages, and significant market share shifts due to online Rx sales are not anticipated before 2025.
Competitive Landscape: Key Players and Projected Market Shares 2025
The Austrian online pharmacy market is characterized by a blend of established DACH-region players and growing domestic entities. Foreign-based online pharmacies, particularly those from Germany, have historically held significant market shares due to their broader product ranges, competitive pricing, and developed logistics infrastructure.
QuantisIntel analysis projects the following market share distribution for the Austrian online pharmacy market by the end of 2025:
- Redcare Pharmacy (formerly Shop Apotheke Europe): This entity, a major player in the DACH region, is projected to maintain its leading position. Its extensive product catalog, aggressive marketing, and robust logistics network are key drivers. Its market share is forecast to be 32.5% by 2025, a slight increase from an estimated 31.0% in 2023, reflecting continued market penetration.
- DocMorris (Zur Rose Group): Another prominent German-based online pharmacy, DocMorris (part of the Zur Rose Group) holds a substantial share. While facing strong competition, its brand recognition and customer loyalty contribute to its position. We project DocMorris to secure 26.0% of the Austrian online pharmacy market by 2025, a marginal decrease from an estimated 27.5% in 2023, indicating a slight erosion to Redcare Pharmacy and domestic players.
- Vamida.at: As a significant domestic Austrian online pharmacy, Vamida benefits from its local focus and tailored offerings. It has been steadily growing its market presence. QuantisIntel forecasts Vamida.at to capture 11.5% of the market by 2025, up from an estimated 9.0% in 2023, demonstrating strong organic growth and local market expertise.
- ApoMed.at / ApoMed Handels GmbH: Another Austrian-based online pharmacy, ApoMed.at focuses on a wide range of health and beauty products. Its market share is projected to reach 7.0% by 2025, an increase from an estimated 6.0% in 2023, driven by a growing customer base and targeted marketing.
- Other Domestic Online Pharmacies (e.g., St. Charles Apotheke Online, etc.): A collective of smaller, often brick-and-mortar pharmacies with online presences, and other niche online retailers. This segment is dynamic and collectively represents a notable portion of the market. Their combined share is projected at 15.0% by 2025, slightly down from 16.0% in 2023, as larger players consolidate market share.
- International Niche Players & General E-commerce Platforms (e.g., Amazon, regional marketplaces): This category includes various other online retailers that offer health and beauty products, some of which directly compete with online pharmacies for certain product categories. Their collective share is projected at 8.0% by 2025, reflecting a stable presence in specific product niches.
| Online Pharmacy Entity | Projected Market Share (2023E) | Projected Market Share (2025E) | Share Change (2023E to 2025E) | |----------------------------------|----------------
| Online Pharmacy Entity | Projected Market Share (2023E) | Projected Market Share (2025E) | Share Change (2023E to 2025E) |
|---|---|---|---|
| Redcare Pharmacy | 31.0% | 32.5% | +1.5 percentage points |
| DocMorris | 27.5% | 26.0% | -1.5 percentage points |
| Vamida.at | 9.0% | 11.5% | +2.5 percentage points |
| ApoMed.at / ApoMed Handels GmbH | 6.0% | 7.0% | +1.0 percentage point |
| Other Domestic Online Pharmacies | 16.0% | 15.0% | -1.0 percentage point |
| International Niche Players & General E-commerce Platforms | 10.5% | 8.0% | -2.5 percentage points |
| Total | 100.0% | 100.0% | 0.0 percentage points |
Note: E = Estimated
Frequently Asked Questions
What is the projected total market volume for the Austrian online pharmacy sector in 2025? The Austrian online pharmacy market is projected to reach an estimated €408 million by the end of 2025. This figure represents a 13.3% growth over 2024, indicating sustained momentum in the sector.
Which online pharmacies are projected to hold the largest market shares in Austria by 2025? Redcare Pharmacy is projected to lead the market with a 32.5% share by 2025. DocMorris is forecast to hold the second-largest share at 26.0%, while the domestic player Vamida.at is expected to secure 11.5%.
What is Redcare Pharmacy’s anticipated market share in the Austrian online pharmacy market for 2025? Redcare Pharmacy (formerly Shop Apotheke Europe) is projected to achieve a 32.5% market share in the Austrian online pharmacy market by 2025. This represents an increase from its estimated 31.0% share in 2023.
Does the Austrian online pharmacy market share data for 2025 include prescription-only (Rx) drugs? The market share projections primarily encompass over-the-counter (OTC) medications, health products, and non-pharmaceutical assortments. Current Austrian law significantly restricts the online sale of prescription-only drugs to end-consumers, meaning Rx drugs do not substantially contribute to these online market share figures.
For deeper strategic analysis, see our full report.
By 2025, the Austrian online pharmacy market is projected to reach €40
PREMIUM REPORT
Get the Full Strategic Breakdown
The free data above is just the surface. Our premium report includes margin analysis, competitive playbooks, and actionable growth strategies.
- Complete margin analysis by category and country
- Competitive playbook with specific company strategies
- Growth projections through Q4 2026
- Regulatory compliance checklist for DACH markets
- Supplier negotiation benchmarks
Senior E-Commerce Analysts
Quantis Intel Research Team
The Quantis Intel research team analyses e-commerce markets across Germany, Austria, and Switzerland. Our data-driven reports combine proprietary metrics with public market data to deliver actionable insights for DACH retailers and brands.